Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yinbin Zhang
Fulvestrant 500mg Versus Exemestane in Postmenopausal Metastatic Breast Cancer (MBC) Resistant to Adjuvant Non-Steroidal Aromatase Inhibitors (NSAI) in Clinical Practice – A Multicenter Retrospective Study
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Review of Hormone-Based Treatments in Postmenopausal Patients With Advanced Breast Cancer Focusing on Aromatase Inhibitors and Fulvestrant
ESMO Open
Cancer Research
Oncology
Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Pcn180 - Pharmacoeconomic Assessment of Fulvestrant Versus Dd (Doxorubicin, Docetaxel) Therapy in Postmenopausal Women With Metastatic Er (+) Her2 (-) Breast Cancer in Ukraine
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
A Retrospective Study of Trifluridine/Tipiracil in Pretreated Metastatic Colorectal Cancer Patients in Clinical Practice
Colorectal Cancer
Oncology
Gastroenterology
Efficacy of Adjuvant Aromatase Inhibitor in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients According to the Body Mass Index
British Journal of Cancer
Cancer Research
Oncology
Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer
Breast Care
Surgery
Oncology
Auricular Point Acupressure to Manage Aromatase Inhibitor–Induced Arthralgia in Postmenopausal Breast Cancer Survivors: A Pilot Study
Oncology Nursing Forum
Oncology
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
